James McCluskey

Active 1983–2026

145
Papers
27,205
Citations
95
h-index
142
i10-index

Citations

Citations per year for James McCluskey1981: 1 citations1983: 1 citations1985: 3 citations1986: 4 citations1987: 5 citations1988: 4 citations1989: 2 citations1990: 4 citations1991: 4 citations1992: 12 citations1993: 6 citations1994: 8 citations1995: 26 citations1996: 28 citations1997: 26 citations1998: 31 citations1999: 57 citations2000: 44 citations2001: 50 citations2002: 77 citations2003: 72 citations2004: 86 citations2005: 105 citations2006: 124 citations2007: 140 citations2008: 170 citations2009: 188 citations2010: 158 citations2011: 210 citations2012: 296 citations2013: 212 citations2014: 267 citations2015: 356 citations2016: 341 citations2017: 301 citations2018: 455 citations2019: 1,033 citations2020: 1,533 citations2021: 1,266 citations2022: 733 citations2023: 646 citations2024: 911 citations2025: 517 citations2026: 24 citations1982: no citations, so this year is not shown1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,180 citing papers, 25.2% of this breakdownUnited Kingdom: 870 citing papers, 10% of this breakdownAustralia: 776 citing papers, 9% of this breakdownChina: 585 citing papers, 6.8% of this breakdownGermany: 457 citing papers, 5.3% of this breakdownFrance: 417 citing papers, 4.8% of this breakdownCanada: 313 citing papers, 3.6% of this breakdownNetherlands: 244 citing papers, 2.8% of this breakdownJapan: 239 citing papers, 2.8% of this breakdownItaly: 229 citing papers, 2.6% of this breakdownSwitzerland: 184 citing papers, 2.1% of this breakdownSweden: 170 citing papers, 2% of this breakdown
0%25.2%Other 23%

Fields

  • Immunology and Microbiology42.6%
  • Medicine34.1%
  • Biochemistry, Genetics and Molecular Biology18.4%
  • Neuroscience1.1%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Agricultural and Biological Sciences0.8%
  • Other2%

Topics

  • Immune Cell Function and Interaction13%
  • T-cell and B-cell Immunology11%
  • Immunotherapy and Immune Responses6.6%
  • vaccines and immunoinformatics approaches3.1%
  • CAR-T cell therapy research3%
  • Monoclonal and Polyclonal Antibodies Research2.7%
  • Other60.6%

Coauthors

All papers

Open in search
  1. T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules

    Authors: , , , , , - Annual Review of Immunology 2014 cited by 819

  2. The biology and functional importance of MAIT cells

    Authors: , , , - Nature Immunology 2019 cited by 589

  3. MR1 presents microbial vitamin B metabolites to MAIT cells

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 1,363

  4. T-cell activation by transitory neo-antigens derived from distinct microbial pathways

    Authors: , , , , , , , , , , , , , , , , , - Nature 2014 cited by 903

  5. More than one reason to rethink the use of peptides in vaccine design

    Authors: , , - Nature Reviews Drug Discovery 2007 cited by 865

  6. The burgeoning family of unconventional T cells

    Authors: , , , , - Nature Immunology 2015 cited by 791

  7. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2013 cited by 598

  8. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells

    Authors: , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2014 cited by 308

  9. Activation and In Vivo Evolution of the MAIT Cell Transcriptome in Mice and Humans Reveals Tissue Repair Functionality

    Authors: , , , , , , , , , , , , - Cell Reports 2019 cited by 228

  10. A three-stage intrathymic development pathway for the mucosal-associated invariant T cell lineage

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2016 cited by 366

  11. Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity

    Authors: , , , , , , , , , , , , , , - Nature Communications 2020 cited by 156

  12. Identification of phenotypically and functionally heterogeneous mouse mucosal-associated invariant T cells using MR1 tetramers

    Authors: , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2015 cited by 383

  13. Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , , , - Nature Immunology 2017 cited by 250

  14. Genome-wide CRISPR–Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1

    Authors: , , , , , , , , , , , , , , , , , , - Nature Immunology 2020 cited by 263

  15. The intracellular pathway for the presentation of vitamin B–related antigens by the antigen-presenting molecule MR1

    Authors: , , , , , , , , , , , - Nature Immunology 2016 cited by 185

  16. Human blood MAIT cell subsets defined using MR1 tetramers

    Authors: , , , , , , , , , , , , , , , , - Immunology and Cell Biology 2018 cited by 272

  17. A molecular basis for the association of the HLA-DRB1 locus, citrullination, and rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2013 cited by 412

  18. Stabilizing short-lived Schiff base derivatives of 5-aminouracils that activate mucosal-associated invariant T cells

    Authors: , , , , , , , , , , - Nature Communications 2017 cited by 161

  19. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

    Authors: , , , , , , , , , , , , , - Nature 2012 cited by 698

  20. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2017 cited by 236

  21. MAIT cells regulate NK cell-mediated tumor immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Phillip K. Darcy - Nature Communications 2021 cited by 104

  22. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals

    Authors: , , , , , , , , , , , , , , , , - Mucosal Immunology 2016 cited by 275

  23. The molecular basis underpinning the potency and specificity of MAIT cell antigens

    Authors: , , , , , , , , , , , , - Nature Immunology 2020 cited by 86

  24. Comprehensive, Quantitative Mapping of T Cell Epitopes in Gluten in Celiac Disease

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2010 cited by 474